Probiotic formula which reduces total cholesterol levels by 12% on average, according to published clinical data.
In addition to its greater efficacy, AB-LIFE has another important difference with respect to other solutions in the market: it not only reduces the levels of cholesterol absorbed from the diet, but also endogenous cholesterol, leading to a decreased blood colesterol level. Therefore, AB-LIFE has an increased effectiveness in a larger number of people. AB-LIFE opens the door to probiotic therapy in preventing cardiovascular disease.
Who is AB-LIFE for?
AB-LIFE is useful for all patients following a nutritional tractament for reducing plasmatic colesterol, and it also works as a complementary tractament for patients being medicated
MAIN TARGET: Patients with 200-300 mg/dl colesterol
- AB-LIFE’s effectiveness has been proven through a clinical study in which 60 volunteers aged between 18 and 65 with total serum cholesterol levels of over 200 mg/dl took part.
- The volunteers participating in the clinical trial who received one capsule of AB-LIFE every day for 12 weeks, showed a decrease in total cholesterol levels of 12% on average. Furthermore, an extremely important reduction in LDL cholesterol of 10% was observed.
- AB-LIFE not only works against plasmatic cholesterol but also against LDL and oxidized LDL, the main risk factor for cardiovascular disease.